Deguelin blocks cells survival signal pathways and induces apoptosis of HL-60 cells in vitro

International Journal of Hematology

Volumn 89, Issue 5, 2009, Pages 618-623

  Chen, Yan ^a   Wu, Qing ^a   Cui, Guo Hui ^a   Chen, Yi Quan ^a   Li, Rui ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Bcl 2; Deguelin; HL 60 cell; P AKT; Survivin

Indexed keywords

DEGUELIN; PROTEIN BCL 2; PROTEIN KINASE B; SURVIVIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; DRUG MECHANISM; HUMAN; HUMAN CELL; IC 50; LEUKEMIA CELL; NICK END LABELING; PROTEIN EXPRESSION; TRANSMISSION ELECTRON MICROSCOPY;

ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL SURVIVAL; HL-60 CELLS; HUMANS; PROTEIN KINASES; ROTENONE; SIGNAL TRANSDUCTION;

EID: 67749109791     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-009-0307-4     Document Type: Article

References (14)

1. S Shin BJ Sung YE Cho 2001 An anti-apoptotic protein human surviving is a direct inhibitor of Caspase-3 and -7 Biochemistry 40 4 1117 1123 10.1021/bi001603q (Pubitemid 32108606)
2. JA Fresno Vara E Casado J de Castro 2004 PI3K/Akt signalling-pathway and cancer J Cancer Treat Rev 30 2 193 204
3. AL Weber A Rahemtullah JA Ferry 2003 Hodgkin and non-Hodgkin lymphoma of the head and neck: clinical, pathologic, and imaging evaluation Neuroimaging Clin N Am 13 371 392 10.1016/S1052-5149(03)00039-X (Pubitemid 37025599)
4. G Murillo GI Salti JW Kosmeder 2002 Deguelin inhibits the growth of colon cancer cells through the induction of apoptosis and cell cycle arrest Eur J Cancer 38 2446 2454 10.1016/S0959-8049(02)00192-2 (Pubitemid 35387498)
5. KH Chun JW Kosmeder S Sun 2003 Effects of deguelin on the phosphatidylinosito1-3 kinase/Akt pathway and apoptosis in premalignant human bronchial epithelial cells J Natl Cancer 95 291 302
6. R Bortul PL Tazzari AM Billi 2005 Deguelin, a PI3K/AKT inhibitor, enhances chemosensitivity of leukaemia cells with an active PI3K/AKT pathway Br J Haematol 129 677 686
7. F Chang JT Lee PM Navolanic 2003 Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy Leukemia 17 590 603 10.1038/sj.leu.2402824 (Pubitemid 36395654)
8. Li-jun M, Jing W. Advances in studies on AKT and tumor, Foreign Medical Science. Sect Pathophysiol Clin Med. 2004;24(5):406-9.
9. Z Cai HY Bao M Lin 2005 Correlation between Survivin mRNA expression and homoharringtonine induced apoptosis of malignant hematopoietic cells Chin Med J 118 548 554
10. AD Schimmer S Dalili 2005 Targeting the IAP family of caspase inhibitors as an emerging therapeutic strategy Hematology Am Soc Hematol Educ Program 1 215 219
11. N Van de Donk MMJ Kamphuis M Van Dijk 2003 Chemo-sensitization of myeloma plasm cells by an anti-sense-mediated downregulation of Bcl-2 protein Leukemia 17 1 211 219 10.1038/sj.leu.2402768 (Pubitemid 36175908)
12. XH Peng P Karna Z Cao 2006 Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression J Biol Chem 281 36 25903 25914 10.1074/jbc.M603414200 (Pubitemid 44401796)
13. M Fornaro J Plescia S Chheang 2003 Fibronectin protects prostate cancer cells from tumor necrosis factor-alpha-induced apoptosis via the AKT/survivin pathway Biol Chem 278 50 50402 50411 10.1074/jbc.M307627200 (Pubitemid 37548884)
14. S Pugazhenthi A Nesterova C Sable 2000 Akt protein kinase B upregulates Bcl-2 expression through camp response element-binding protein J Biol Chem 275 15 10761 10766 10.1074/jbc.275.15.10761 (Pubitemid 30212704)